Other skin disorders homepage

Other skin disorders

Even mild skin disease can cause significant distress for patients, due to associated visibility and stigma, and this is of particular relevance for conditions which affect
...

Read more on Other skin disorders

FDA approves Dupixent to treat adolescents with atopic dermatitis

The FDA has approved Dupixent (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose...

Added 19 days ago Drug news

Two phase III studies of KX2 391 ointment meet primary endpoints in actinic keratosis

Almirall and Athenex announced that an oral presentation reporting the results from two Phase III studies of KX2 391 ointment...

Added 24 days ago Congress news

AAD 2019 preview | Find out more

Search all news articles for Other skin disorders

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

Guidelines

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017

The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic therapies (adalimumab, etanercept, infliximab, ixekizumab, secukinumab and ustekinumab) in adults, children and young people...

Added 9 years ago

British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017

The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of actinic keratosis (AK).

Added 1 year ago

Canadian Guidelines for the Management of Plaque Psoriasis 2009

Since the publication of the 2009 Canadian Guidelines for the Management of Plaque Psoriasis, significant advances have been made in determining the role of T cells in inflammatory and autoimmune diseases.

Added 2 years ago

Search all guidelines for Other skin disorders

Journal articles

A novel nicastrin mutation in a three generation Dutch family with hidradenitis suppurativa

Hidradenitis suppurativa (HS) compromises a multifactorial pathogenesis with a largely unclear aetiology.

Added 1 year ago

Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa

Introduction: Hidradenitis suppurativa (HS) is a serious, debilitating, chronic inflammatory skin disease. Adalimumab is a fully human, immunoglobulin G1 monoclonal antibody specific for tumor necrosis factor-alpha...

Added 1 year ago

NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?

NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa

Added 1 year ago

Search all journal articles for Other skin disorders

Clinical trials

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Added 2 years ago

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting.

Added 2 years ago

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study) (SHARPS)

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

Added 2 years ago

Search all clinical trials for Other skin disorders

Lauren McCracken

Lauren McCracken works for our sister agency Digital Medical Communications (DMC Ltd) as an Associate Medical Writer. Lauren is very passionate about healthcare and how technology can improve treatments, and has written a blog series 'Transforming lives through technology'

Accrediting body: Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available: 1
Registration required: 1
Subscription fee: FREE

Managing CSU and its comorbidities: from primary to secondary care

Accrediting body: Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available: 1
Registration required: 1
Subscription fee: FREE

Management of hidradenitis suppurativa

Accrediting body: BMJ Learning - British Medical Learning
Credits available: 1
Registration required: 1
Subscription fee: 90

Search all CME for Other skin disorders

Alternatively login via

Google +

A

C

D

E

G

H

I

M

N

O

P

R

S

T

U

A

C

D

H

I

L

M

N

O

P

R

A

B

C

Learning Zones in English